5291 - 5300 of 6258 Results
Title
Year
-
OPENTitle: Alternative splicing impacts microRNA regulation within coding regionsJournal Name: NAR Genomics and BioinformaticsPublisher: Oxford University Press (OUP)Vol: 5Issue #: 3Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/nargab/lqad081Best OA location URL: https://academic.oup.com/nargab/article-pdf/5/3/lqad081/51517202/lqad081.pdfCitation Count: 5
- Scalable Nanopore sequencing of human genomes provides a comprehensive view of haplotype-resolved variation and methylation2023OPENTitle: Scalable Nanopore sequencing of human genomes provides a comprehensive view of haplotype-resolved variation and methylationJournal Name: Nature MethodsPublisher: Springer Science and Business Media LLCVol: 20Issue #: 10Start Page: 1483End Page: 1492Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/s41592-023-01993-xBest OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/11222905Citation Count: 92
-
OPENTitle: Unique functional responses differentially map onto genetic subtypes of dopamine neuronsJournal Name: Nature NeurosciencePublisher: Springer Science and Business Media LLCVol: 26Issue #: 10Start Page: 1762End Page: 1774Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1038/s41593-023-01401-9Best OA location URL: https://www.nature.com/articles/s41593-023-01401-9.pdfCitation Count: 115
- CSF proteome profiling reveals biomarkers to discriminate dementia with Lewy bodies from Alzheimer´s disease2023OPENTitle: CSF proteome profiling reveals biomarkers to discriminate dementia with Lewy bodies from Alzheimer´s diseaseJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 14Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41467-023-41122-yBest OA location URL: https://www.nature.com/articles/s41467-023-41122-y.pdfCitation Count: 34
-
OPENTitle: A step forward for LRRK2 inhibitors in Parkinson’s diseaseJournal Name: Science Translational MedicinePublisher: American Association for the Advancement of Science (AAAS)Vol: 14Issue #: 648Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1126/scitranslmed.abq7374Best OA location URL: https://discovery.ucl.ac.uk/10150053/1/abq7374_acceptedversion.pdfCitation Count: 18
- Disease Progression, Resilience, and Inflammation Markers During the Coronavirus Disease 2019 Pandemic in Parkinson's Disease2022OPENTitle: Disease Progression, Resilience, and Inflammation Markers During the Coronavirus Disease 2019 Pandemic in Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 11Start Page: 2315End Page: 2317Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.29212Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.29212Citation Count: 5
-
OPENTitle: Viewpoint on Milestones for Fellowship Training in Movement DisordersJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 8Start Page: 1605End Page: 1609Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.29146Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.29146Citation Count: 2
- Repeat‐Associated Non‐AUG Translation of AGAGGG Repeats that Cause X‐Linked Dystonia‐Parkinsonism2022OPENTitle: Repeat‐Associated Non‐AUG Translation of AGAGGG Repeats that Cause X‐Linked Dystonia‐ParkinsonismJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 11Start Page: 2284End Page: 2289Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.29183Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.29183Citation Count: 8
- Effect of Opicapone on Levodopa Pharmacokinetics in Patients with Fluctuating Parkinson's Disease2022OPENTitle: Effect of Opicapone on Levodopa Pharmacokinetics in Patients with Fluctuating Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 11Start Page: 2272End Page: 2283Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.29193Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.29193Citation Count: 23
- Neurofilament Light Protein as a Potential Blood Biomarker for Huntington's Disease in Children2022OPENTitle: Neurofilament Light Protein as a Potential Blood Biomarker for Huntington's Disease in ChildrenJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 7Start Page: 1526End Page: 1531Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.29027Best OA location URL: https://doi.org/10.1002/mds.29027Citation Count: 17